HREBA_Cancer_Committee

 

Overview

The Health Research Ethics Board of Alberta Cancer Committee (HREBA-CC) provides scientific and ethical review of all cancer-related protocols involving human participants in the province of Alberta.

Researchers:  Information on how to locate your electronic study information and adjust it, is listed under Managing a Study in the menu on the right.  You will need an IRISS login either from the University of Calgary or from HREBA.  More information can be found here.

 

Meeting Dates and Deadlines

The HREBA Cancer Committee meets twice a month.

There are two deadlines for each meeting:

  1. applications and amendments must be must be received by the Cancer Committee office two weeks before the Cancer Committee meeting.  This is the submission deadline.  Check here for specific dates: 2018 Cancer Committee Dates and Deadlines.
  2. renewals must be received one week before the meeting date.
 Please note: there are no exceptions to the noon submission deadline.

Minimal risk applications including chart reviews, image reviews and laboratory based studies are processed through the delegated review pathway.

Multiple Sites in Alberta

For clinical trials conducted by multiple principal investigators at sites within AHS Cancer Control there is a single review process to reduce duplication of ethics review and the associated administrative burden.  This process requires increased communication among researchers, research teams, Clinical Research Unit staff, and the HREBA-CC administrative staff.

Standard Operating Procedures

HREBA has adopted the Standard Operating Procedures (SOPs) developed by the Network of Networks (N2) and the Canadian Association of Research Ethics Boards (CAREB).  These SOPS are compliant with applicable Canadian and US regulatory and ethics guidance criteria.  They facilitate the distribution, adoption and maintenance of a single set of standards for REBs in Canada.

Use of SOPs also ensures that the ethics board is constituted appropriately and protects the rights and safety of study participants.

You may find them listed here with links to the pdf documents.

 UPDATE: The 90 day renewal notification which is automatically generated by IRISS for studies which are submitted electronically to the Cancer Committee is no longer being sent.

Fees

Industry funded studies are charged a fee for review. An invoice will be sent from Alberta Innovates for the amount indicated below after the ethics certificate is granted i.e. the study is approved. GST will be added if applicable.

Please do not send in the review fee until you receive an invoice.

Type of Review Fee
Full Review $4000.00
Delegated Review

Includes minimal risk, additional investigator (multisite) and reciprocal reviews.

$1000.00

This applies only to industry funded studies received by HREBA after July 1st, 2017.

Contact Information

Rakhi Chandra
Ethics Coordinator
HREBA Cancer Committee
Email: cancer@hreba.ca
Phone: 1-877-423-5727 x 299
Bindya Mathew
Acting Ethics Coordinator
HREBA Cancer Committee
Email: cancer@hreba.ca
Phone: 1-877-423-5727 x 222
Magda Piwowarczyk
Acting Ethics Coordinator
HREBA Cancer Committee
Email: cancer@hreba.ca
Phone: 1-877-423-5727 x 282